Jun Okui

Tokyo, 1608582, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 51 publications

Recommendations for generating real-world evidence with regulatory-grade relevance and reliability.

Recommendations for generating real-world evidence with regulatory-grade relevance and reliability.

Journal: International journal of clinical oncology

Published: June 09, 2026

Response to Zhang and Lu.

Response to Zhang and Lu.

Journal: Journal of the National Cancer Institute

Published: May 14, 2026

Immunotherapy Response in Microsatellite Instability-High Gastroesophageal Adenocarcinoma.

Immunotherapy Response in Microsatellite Instability-High Gastroesophageal Adenocarcinoma.

Journal: JAMA surgery

Published: April 15, 2026

Robotic Gastrectomy and Delivery of Adjuvant Systemic Therapy in Locally Advanced Gastric Adenocarcinoma: An NCDB Propensity Score-Matched Analysis.

Robotic Gastrectomy and Delivery of Adjuvant Systemic Therapy in Locally Advanced Gastric Adenocarcinoma: An NCDB Propensity Score-Matched Analysis.

Journal: Cancers

Published: March 03, 2026

Survival after pathological complete response following neoadjuvant chemotherapy versus chemoradiotherapy for oesophageal squamous cell carcinoma.

Survival after pathological complete response following neoadjuvant chemotherapy versus chemoradiotherapy for oesophageal squamous cell carcinoma.

Journal: The British journal of surgery

Published: December 23, 2025

Conditional recurrence-free survival after curative esophagectomy: individual patient data analysis of 11 trials.

Conditional recurrence-free survival after curative esophagectomy: individual patient data analysis of 11 trials.

Journal: Journal of the National Cancer Institute

Published: October 08, 2025

Can combined organ resection cure T4 esophageal cancer? Insights from a multi-institutional study of incomplete resection cases.

Can combined organ resection cure T4 esophageal cancer? Insights from a multi-institutional study of incomplete resection cases.

Journal: Esophagus : official journal of the Japan Esophageal Society

Published: September 17, 2025

Safety Comparison of Risk of Liver Dysfunction between Generic and Brand Statin Drugs Marketed in Japan: A Cohort Study Using MID-NET®.

Safety Comparison of Risk of Liver Dysfunction between Generic and Brand Statin Drugs Marketed in Japan: A Cohort Study Using MID-NET®.

Journal: Therapeutic innovation & regulatory science

Published: July 16, 2025

Transpacific multicenter collaborative study of minimally invasive proximal gastrectomy vs. minimally invasive total gastrectomy for proximal gastric and gastroesophageal junction cancers: 3-month follow-up results.

Transpacific multicenter collaborative study of minimally invasive proximal gastrectomy vs. minimally invasive total gastrectomy for proximal gastric and gastroesophageal junction cancers: 3-month follow-up results.

Journal: Surgical endoscopy

Published: July 10, 2025

Safety and efficacy of long-shelf-life allogeneic adipose-derived mesenchymal stem cell line-derived platelet-like cells for refractory foot ulcers: A translational preclinical and phase 1/2a study.

Safety and efficacy of long-shelf-life allogeneic adipose-derived mesenchymal stem cell line-derived platelet-like cells for refractory foot ulcers: A translational preclinical and phase 1/2a study.

Journal: Regenerative therapy

Published: June 05, 2025

Additional treatment for esophageal cancer patients with incomplete resection due to the surrounding organ invasion: a nationwide survey of 45 Japanese centers.

Additional treatment for esophageal cancer patients with incomplete resection due to the surrounding organ invasion: a nationwide survey of 45 Japanese centers.

Journal: Esophagus : official journal of the Japan Esophageal Society

Published: May 15, 2025

Plasma Fibrinogen Predicts Response to Immune Checkpoint Inhibitor by Inflammatory Tumor Microenvironment in Esophageal Cancer.

Plasma Fibrinogen Predicts Response to Immune Checkpoint Inhibitor by Inflammatory Tumor Microenvironment in Esophageal Cancer.

Journal: Cancer medicine

Published: May 10, 2025

Showing 1-12 of 51

Last Updated: 09/26/2026